You are here: Industry Insights > Cryoport

News List

Cryoport Partners with Cell Matters to Deliver Cryopreservation Services contractpharma
January 27, 2022
Further strengthens Cryport’s capabilities in the EMEA region.
Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients contractpharma
June 23, 2021
Cellenkos Inc., a privately held, clinical-stage biotechnology company, has selected Cryoport to provide a staged, on-demand, logistics solution for Covid-19 therapy shipments for patients in need.
Cellenkos® Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need prnewswire
June 23, 2021
Cryoport, Inc. today announced that Cellenkos®, Inc., a privately held, clinical-stage biotechnology company, has selected Cryoport to provide a staged, on-demand, logistics solution for COVID-19 therapy shipments for patients in need.
Cryoport Systems and CRYOPDP Jointly Open Global Logistics Center contractpharma
May 28, 2021
The Singapore location is another step in Cryoport's strategy to strengthen its footprint in the Asia Pacific region.
Cryoport Acquires Critical Transport Solutions Australia contractpharma
April 08, 2021
Cryoport, Inc., a global provider of temperature-controlled supply chain solutions for the life sciences, has acquired Critical Transport Solutions Australia Pty Ltd. (CTSA), a provider of healthcare logistics management services, for approximately ...
Cryoport Launches ESG Program contractpharma
March 02, 2021
Cryoport, Inc., a provider of temperature-controlled supply chain solutions for the life sciences industry, has launched its Environmental, Social & Governance (ESG) initiative.
Cryoport to Acquire MVE Biological Solutions contractpharma
August 26, 2020
Further expands its footprint of solutions and services, in particular to the growing cell and gene market.
Cryoport to Acquire CRYOPDP contractpharma
August 24, 2020
Expands Cryoport’s global supply chain network and services with more than 220 employees located in 22 global facilities in 12 countries.
Medipal Holdings Partners with Cryoport contractpharma
August 10, 2020
Cryoport Inc. and Medipal Holdings Corporation have announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan.
Cryoport, Medipal Partner on Supply Chain Solutions for Japanese Market contractpharma
August 05, 2020
Will partner to provide integrated distribution solutions for specialty cell and gene therapies that demand stringent temperature control.

Previous page 1 2 Next page